https://philadelphia-pharma.com
[tek_reviewcarousel_single rw_author_name="Will Chu, CRTonline.org" rw_author_desc="Posted: 09/19/2022" rw_author_image="18961" rw_review_title="Short-Term Use of Rivaroxaban" rw_review_message="Short-term use of rivaroxaban can reduce incidences of radial artery occlusion (RAO) by 50%, according to a study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 conference in Boston. The RIVARAD trial found a 10-mg dose of rivaroxaban given to patients
Platform: WooCommerce
Technologies used: Google Adsense, Google Analytics 4, Google Tag Manager, Yoast, YouTube Player
Contact page: https://philadelphia-pharma.com/contact
Signup for Free. No Credit Card required.Suitable for marketing agencies, app developers and new business ideas.
No credit card required.